Protective effects of HBSP on ischemia reperfusion and cyclosporine a induced renal injury

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Wu, Yuanyuan ^a   Zhang, Junlin ^b   Liu, Feng ^b   Yang, Cheng ^c   Zhang, Yufang ^a   Liu, Aifen ^a   Shi, Lan ^b   Wu, Yajun ^b   Zhu, Tongyu ^c   Nicholson, Michael L ^d   Fan, Yaping ^b   Yang, Bin ^a,b,d  

^a Nantong Vocational University   (China)

^b NANTONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CREATININE; CYCLOSPORIN A; ERYTHROPOIETIN; HELIX B SURFACE PEPTIDE; NITROGEN; PEPTIDE; UNCLASSIFIED DRUG; UREA; CYCLOSPORIN; GLUTAMINYL GLUTAMYL GLUTAMINYL LEUCYL GLUTAMYL ARGINYL ALANYL LEUCYL ASPARAGYL SERYL SERINE; GLUTAMINYL-GLUTAMYL-GLUTAMINYL-LEUCYL-GLUTAMYL-ARGINYL-ALANYL-LEUCYL-ASPARAGYL-SERYL-SERINE; MESSENGER RNA; PEPTIDE FRAGMENT; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; INFLAMMATION; INFLAMMATORY CELL; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; REPERFUSION INJURY; TISSUE SECTION; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; ANIMAL; APOPTOSIS; ENZYME ACTIVATION; FIBROSIS; GENE EXPRESSION; GENETICS; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CASPASE 3; CYCLOSPORINE; ENZYME ACTIVATION; ERYTHROPOIETIN; FIBROSIS; GENE EXPRESSION; INFLAMMATION; KIDNEY; KIDNEY FUNCTION TESTS; MALE; PEPTIDE FRAGMENTS; PROTECTIVE AGENTS; RATS; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84888868176     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/758159     Document Type: Article

References (26)

1. Daemen M. A., de Vries B., Buurman W. A., Apoptosis and inflammation in renal reperfusion injury. Transplantation 2002 73 11 1693 1700 2-s2.0-0037096712 (Pubitemid 34655241)
2. Coulson M. T., Jablonski P., Howden B. O., Thomson N. M., Stein A. N., Beyond operational tolerance: effect of ischemic injury on development of chronic damage in renal grafts. Transplantation 2005 80 3 353 361 2-s2.0-23744445570 10.1097/01.tp.0000168214.84417.7d (Pubitemid 41129964)
3. Lee R. A., Gabardi S., Current trends in immunosuppressive therapies for renal transplant recipients. American Journal of Health-System Pharmacy 2012 69 22 1961 1975
4. Bennett W. M., Insights into chronic cyclosporine nephrotoxicity. International Journal of Clinical Pharmacology and Therapeutics 1996 34 11 515 519 2-s2.0-0029987555 (Pubitemid 26386039)
5. Reis F. N., The unsolved cyclosporine-induced kidney injury: is paricalcitol a feasible new renoprotective option? Kidney International 2010 77 12 1055 1057 2-s2.0-77956930803 10.1038/ki.2010.93
6. Xiao Z., Li C., Shan J., Luo L., Feng L., Lu J., Li S., Long D., Li Y., Mechanisms of renal cell apoptosis induced by cyclosporine A: a systematic review of in vitro studies. American Journal of Nephrology 2011 33 6 558 566 2-s2.0-80053952635 10.1159/000328584
7. Yang B., Jain S., Pawluczyk I. Z. A., Imtiaz S., Bowley L., Ashra S. Y., Nicholson M. L., Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats. Kidney International 2005 68 5 2050 2067 2-s2.0-30944469853 10.1111/j.1523-1755.2005.00662.x (Pubitemid 43117780)
8. Yang B., Jain S., Ashra S. Y., Furness P. N., Nicholson M. L., Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation 2006 81 10 1442 1450 2-s2.0-33744935778 10.1097/01.tp.0000209412.77312.69 (Pubitemid 43847156)
9. Brines M., Cerami A., Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. Journal of Internal Medicine 2008 264 5 405 432 2-s2.0-53549097076 10.1111/j.1365-2796.2008.02024.x
10. Brines M., Grasso G., Fiordaliso F., Sfacteria A., Ghezzi P., Fratelli M., Latini R., Xie Q.-W., Smart J., Su-Rick C.-J., Pobre E., Diaz D., Gomez D., Hand C., Coleman T., Cerami A., Erythropoietin mediates tissue protection through an erythropoietin and common β -subunit heteroreceptor. Proceedings of the National Academy of Sciences of the United States of America 2004 101 41 14907 14912 2-s2.0-6944237300 10.1073/pnas.0406491101 (Pubitemid 39410773)
11. Yang B., Hosgood S. A., Bagul A., Waller H. L., Nicholson M. L., Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1 β in isolated hemoperfused kidneys. European Journal of Pharmacology 2011 660 2-3 420 430 2-s2.0-79956122786 10.1016/j.ejphar.2011.03. 044
12. Hu L., Yang C., Zhao T., Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation. Journal of Surgical Research 2012 176 1 260 266
13. Varet B., Casadevall N., Lacombe C., Nayeaux P., Erythropoietin: physiology and clinical experience. Seminars in Hematology 1990 27 3 25 31 2-s2.0-0025282705 (Pubitemid 20214487)
14. Khorana A. A., Francis C. W., Culakova E., Lyman G. H., Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005 104 12 2822 2829 2-s2.0-29144486069 10.1002/cncr.21496 (Pubitemid 41798294)
15. Brines M., Patel N. S. A., Villa P., Brines C., Mennini T., De Paola M., Erbayraktar Z., Erbayraktar S., Sepodes B., Thiemermann C., Ghezzi P., Yamin M., Hand C. C., Xie Q.-W., Coleman T., Cerami A., Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10925 10930 2-s2.0-49449099816 10.1073/pnas.0805594105
16. Ueba H., Brines M., Yamin M., Umemoto T., Ako J., Momomura S.-I., Cerami A., Kawakami M., Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin. Proceedings of the National Academy of Sciences of the United States of America 2010 107 32 14357 14362 2-s2.0-77956291349 10.1073/pnas.1003019107
17. Yang C., Zhao T., Lin M., Helix B surface peptide administered after insult of ischemiareperfusion improved renal function, structure and apoptosisthrough beta common receptor/erythropoietin receptor andPI3K/Akt pathway in a murine model. Experimental and Biology Medicine 2013 238 1 111 119
18. Shihab F. S., Cyclosporine nephropathy: pathophysiology and clinical impact. Seminars in Nephrology 1996 16 6 536 547 2-s2.0-0029857451 (Pubitemid 26395517)
19. Ito H., Kasagi N., Shomori K., Osaki M., Adachi H., Apoptosis in the human allografted kidney: analysis by terminal deoxynucleotidyl transferase-mediated DUTP-botin nick end labeling. Transplantation 1995 60 8 794 798 2-s2.0-0028841040
20. Ortiz A., Justo P., Catalán M. P., Sanz A. B., Lorz C., Egido J., Apoptotic cell death in renal injury: the rationale for intervention. Current Drug Targets. Immune, Endocrine and Metabolic Disorders 2002 2 2 181 192 2-s2.0-0036637177
21. Patel N. S. A., Sharples E. J., Cuzzocrea S., Chatterjee P. K., Britti D., Yaqoob M. M., Thiemermann C., Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney International 2004 66 3 983 989 2-s2.0-4344675279 10.1111/j.1523-1755.2004. 00847.x (Pubitemid 39121002)
22. Patel N. S., Kerr-Peterson H. L., Brines M., Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury. Molecular Medicine 2012 18 1 719 727
23. Hashiguchi H., Morooka H., Miyoshi H., Matsumoto M., Koji T., Sumikawa K., Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesthesia and Analgesia 2005 101 6 1584 1589 2-s2.0-28344437669 10.1213/01.ANE.0000184044.51749.B8 (Pubitemid 41720601)
24. Lee S. H., Li C., Lim S. W., Ahn K. O., Choi B. S., Kim Y. S., Moon I. S., Kim J., Bang B. K., Yang C. W., Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. American Journal of Nephrology 2005 25 1 64 76 2-s2.0-20244390303 10.1159/000084275 (Pubitemid 40529278)
25. Shihab F. S., Bennett W. M., Yi H., Andoh T. F., Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity. Transplantation 2005 79 4 419 426 2-s2.0-14044262258 10.1097/01.TP.0000151721. 99418.48 (Pubitemid 40280173)
26. Haylor J. L., Harris K. P. G., Nicholson M. L., Waller H. L., Huang Q., Yang B., Atorvastatin improving renal ischemia reperfusion injury via direct inhibition of active caspase-3 in rats. Experimental Biology and Medicine 2011 236 6 755 763 2-s2.0-79958844511 10.1258/ebm.2011.010350